CT HB05727 | 2023 | General Assembly

Status

Spectrum: Partisan Bill (Democrat 3-0)
Status: Introduced on January 18 2023 - 25% progression, died in committee
Action: 2023-02-03 - Public Hearing 02/07
Pending: Joint General Law Committee
Text: Latest bill text (Introduced) [PDF]

Summary

To provide that no prescription drug manufacturer may sell a prescription drug in this state at a price that exceeds such drug's reference price.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

An Act Concerning Prescription Drug Costs.

Sponsors


Roll Calls

2023-01-31 - Joint - GL Vote Tally Sheet (Reserved for Subject Matter Public Hearing) (Y: 0 N: 0 NV: 0 Abs: 0) [PASS]

History

DateChamberAction
2023-02-03HousePublic Hearing 02/07
2023-01-31HouseReserved for Subject Matter Public Hearing
2023-01-18HouseReferred to Joint Committee on General Law

Connecticut State Sources


Bill Comments

feedback